Drug Type Stem cell therapy |
Synonyms Alzheimer's disease(GABAeron) |
Target |
Mechanism apolipoprotein E4 modulators, Cell replacements, GABA modulators(Gamma-aminobutyric acid modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | 27 Aug 2024 |